June 2, 2020 - Jeena Scriptech Alpha Advisors

https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20200602-41

1. Scrip code : 500119
Name : Dhampur Sugar Mills Ltd.,
Subject : Outcome Of Board Meeting
a. Approved the closure of operations of Ehaat Limited (Wholly Owned Subsidiary of the Company – The same is not Material subsidiary of the Company). b. Approved Annual Standalone Financial Statements for the year ended 31st March, 2020. c. Approved Annual Consolidated Financial Statements for the year ended 31st March, 2020. d. Recommended commission for Financial Year 2019-20 to Non-Executive Independent Directors, subject to approval of shareholders at the forthcoming Annual General Meeting of the Company. e. Recommended Invitation and Acceptance of Fixed Deposits from the Members and Public, subject to approval of shareholders at the forthcoming Annual General Meeting of the Company. f. Approved date of Annual General Meeting of the Company to be held on Tuesday, the 29th September, 2020.

2. Scrip code : 532281
Name : HCL Technologies Ltd
Subject : Announcement under Regulation 30 (LODR)-Press Release / Media Release
Subject: Release – ‘Temenos and HCL Technologies sign exclusive agreement to market Temenos’ Multiexperience Development Platform to non-financial services enterprises’ Dear Sir/ Madam, Enclosed please find a release on the captioned subject being issued by the Company today. This is for your information and records.

Advanced Enzyme Technologies Ltd

Textiles
FV – Rs 2; 52wks H/L – 225/91.05; TTQ – 5528; CMP – Rs 153 (As On June 2, 2020);

Market Cap – Rs 1712 Crs

Consolidated Financials and Valuations (Amt in Rs Crs unless specified)

	Equity Capital	Net worth	Long Term Debt	Total Sales	PAT	BV (Rs)	EPS (Rs)	P/E	Industry P/E	P/BV	Promoter’s Stake
FY20	22.34	839	16	450	133	75	11.9	12.9	16.18	2.04	57.88
FY19	22.33	679	28	425	111	61	9.95	15.4	16.18	2.5	57.86
Q3 FY20	22.34	777	19	338	100	70	8.9	17.2	16.18	2.2	57.88

Debt to Equity – 0.02

ROE – 16%

Market Cap/Sales – 3.8

Overview:

Advanced Enzyme Technologies Limited (AETL) is a research driven company with global leadership in the manufacturing of enzymes and probiotics.
They are the largest Indian enzyme company, engaged in the research and development, manufacturing and marketing of 400+ proprietary products developed from over 68+ indigenous enzymes and probiotics.
The company is committed to providing eco-safe solutions to a wide variety of industries like human health care and nutrition, animal nutrition, baking, fruit & vegetable processing, brewing & malting, grain processing, protein modification, dairy processing, speciality applications, textile processing, leather processing, paper & pulp processing, bio-fuels, bio-mass processing, bio-catalysis, etc.
AETL comprises of four wholly owned direct subsidiaries, two subsidiaries (60% & 70%) and five step-down wholly owned subsidiaries
The company has 7 plants on operational basis in India and overseas.

Key Updates:

The company acquired in this quarter a land of 15 acre in Nasik and that they are building a modern R&D center and we are thinking about Rs.100 Crores in the next 3 years as a capital investment for the R&D center.
The company mentioned in the earning call of Q3 that they plan to grow at 15 – 20% on yoy basis.

Contribution to Revenue:

Segments	2020 %	2019 %
Human Nutrition	75	76
Animal Nutrition	12	12
Bio- Processing Segment	13	12
Total	100	100

43% revenue is from India and 57% from Overseas.

On the Operations front, capacity utilization is in the range of 52%-55%.

Geographical Revenue Split:

Revenue	2020 (%)	2019 (%)
Asia (ex- India)	6	4
Others	2	2
India	43	40
Europe	7	5
USA	42	49
Total	100	100

Management:

V. L. Rathi – Chairman
Beni Prasad Rauks – CFO

Major Holdings:

Subsidiaries Performance:

Subsidiaries	Revenue	PAT
	(Rs. Crs)
Advanced Bio-Agro Tech Ltd	40	5.5
Advanced EnzyTech Solutions	9	0.5
JC Biotech Private Ltd	49	9.8
Advanced Supplementary Technologies Corporation	213	82
*Advanced Enzymes (Malaysia) Sdn. Bhd	Trial basis	-0.5
Advanced Enzymes Europe B.V.	17	-12
evoxx technologies GmbH	17	-6

* The said subsidiary was acquired in 2017 (incorporated in 2016) will be engaged in supplying and providing enzyme based solutions for extraction of palm oil from palm fruits.

Share Price Trend: